Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.

od Neu, H C, Meropol, N J, Fu, K P
Izdano 1981

Patient–physician discordance in goals of care for patients with advanced cancer

od Douglas, S.L., Daly, B.J., Meropol, N.J., Lipson, A.R.
izdano v Curr Oncol (2019)

Constructs of burden of illness in older patients with breast cancer: a comparison of measurement methods.

od Mandelblatt, J S, Bierman, A S, Gold, K, Zhang, Y, Ng, J H, Maserejan, N, Hwang, Y T, Meropol, N J, Hadley, J, Silliman, R A
Izdano 2001

Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer

od Dotan, E, Meropol, N J, Zhu, F, Zambito, F, Bove, B, Cai, K Q, Godwin, A K, Golemis, E A, Astsaturov, I, Cohen, S J
Izdano 2012

Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer

od Cohen, S J, Konski, A A, Putnam, S, Ball, D S, Meyer, J E, Yu, J Q, Astsaturov, I, Marlow, C, Dickens, A, Cade, D N, Meropol, N J
Izdano 2014

Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours

od Zurita, A J, Khajavi, M, Wu, H-K, Tye, L, Huang, X, Kulke, M H, Lenz, H-J, Meropol, N J, Carley, W, DePrimo, S E, Lin, E, Wang, X, Harmon, C S, Heymach, J V
izdano v Br J Cancer (2015)

Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers

od MANNE, S., KASHY, D., ALBRECHT, T., WONG, Y.-N., FLAMM, A. LEDERMAN, BENSON, A. B., MILLER, S.M., FLEISHER, LINDA, BUZAGLO, J., ROACH, N., KATZ, M., ROSS, E., COLLINS, M., POOLE, D., RAIVITCH, S., MILLER, D.M., KINZY, T.G., LIU, T., MEROPOL, N.J.
izdano v Eur J Cancer Care (Engl) (2014)